Zimbabwe has rejected a significant American healthcare agreement worth $367m (£272m) over five years because of Washington's insistence on confidential biological samples.
The decision came to light after a government memo from December was disclosed, which showed Head of State Emmerson Mnangagwa deemed the agreement was "lopsided".
A government spokesperson later stated that the United States was seeking health data for research and commercial purposes but refused to share the benefits from future treatments.
"We must now begin the difficult and regrettable process of ending our health aid in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the US had furnished more than $1.9bn as health assistance to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has appealed for further dialogue to secure a deal agreeable to all parties so the country's vital HIV programme can continue.
Wider Implications
Zimbabwe's decision comes after a comparable case in neighbouring Kenya, where a high court halted a related health funding agreement after legal challenges were raised about the safety of Kenyans' health data.
Since resuming the presidency recently, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).
The agency had managed assistance for the American government, but Trump claimed its spending was "wasteful" and his government was pursuing government-to-government deals to boost transparency and responsibility.
As per statements, Sixteen nations in Africa have so far signed similar health pacts, representing over $18.3bn in new funding.
Details of the Declined Deal
The money for Zimbabwe was intended to gone towards "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this cooperation could have provided immense benefits for Zimbabwean communities, particularly the 1.2 million currently on HIV treatment through American-funded initiatives," the Ambassador commented.
However, official spokesman Nick Mangwana said the proposed deal was "unfair".
"The proposal required Zimbabwe to provide its genetic material and health information over an extended period, with no equivalent assurance of access to any medical innovations – such as vaccines, diagnostics, or treatments – that might result from that shared data," Mangwana explained.
"Put simply, our nation would supply the raw materials for scientific discovery with no assurance that the final treatments would be available to our citizens should a future health crisis emerge."
Sovereignty and Global Health
Mangwana further noted that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were undermining structures previously established via the international health agency.
Mangwana cited its Pathogen Access and Benefit Sharing scheme designed to manage potential global health emergencies.
"This framework is designed to guarantee that when a country provides its samples, the benefits – such as vaccines and treatments – are shared equitably, not monopolised solely by those with the capability to develop them."
Zimbabwe's reservations over the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We encourage ongoing dialogue with our US partners on how subsequent co-operation might be designed in a manner that honours the sovereignty and interests of each country."
Medical Community Reaction
Medical experts expressed it recognised the government's concerns, but recommended that negotiations need to persist given that a large portion of the country's HIV programmes were funded by foreign aid.
"If specific concerns arise, such as those involving data governance or agreement terms, these can often be addressed via technical clarification and negotiated safeguards," the group said.
This impasse emphasises the ongoing tensions between accepting much-needed foreign assistance and protecting a country's data in an increasingly interconnected world.